Open AccessCost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson’s Disease
Author(s) -
Constant V. M. Verschuur,
Sven R. Suwijn,
Rob J. de Haan,
Judith A. Boel,
Bart Post,
B.R. Bloem,
J.J. van Hilten,
Teus van Laar,
Gerrit Tissingh,
Alexander G. Munts,
Marcel G. W. Dijkgraaf,
Rob M.A. de Bie
Publication year - 2022
Publication title -
journal of parkinson's disease/journal of parkinson's disease (online)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.747
H-Index - 45
eISSN - 1877-718X
pISSN - 1877-7171
DOI - 10.3233/jpd-223247
Subject(s) - levodopa , medicine , carbidopa , quality adjusted life year , cost–utility analysis , quality of life (healthcare) , physical therapy , placebo , cost effectiveness , parkinson's disease , pediatrics , disease , risk analysis (engineering) , alternative medicine , nursing , pathology